Form preview

Get the free Form FDA 1571 - Investigational New Drug Application

Get Form
We are not affiliated with any brand or entity on this form
Illustration
Fill out
Complete the form online in a simple drag-and-drop editor.
Illustration
eSign
Add your legally binding signature or send the form for signing.
Illustration
Share
Share the form via a link, letting anyone fill it out from any device.
Illustration
Export
Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
Form preview

What is FDA 1571 IND

The Form FDA 1571 is a government document used by sponsors to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA).

pdfFiller scores top ratings on review platforms

Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Show more Show less
Fill fillable FDA 1571 IND form: Try Risk Free
Rate free FDA 1571 IND form
4.5
satisfied
24 votes

Who needs FDA 1571 IND?

Explore how professionals across industries use pdfFiller.
Picture
FDA 1571 IND is needed by:
  • Clinical trial sponsors looking to initiate drug investigations.
  • Organizations conducting pharmaceutical research and development.
  • Attorneys or agents facilitating drug application processes.
  • Regulatory compliance teams within pharmaceutical companies.
  • Researchers and scientists involved in drug trials.

Comprehensive Guide to FDA 1571 IND

What is the Form FDA 1571 - Investigational New Drug Application?

Form FDA 1571 is a critical document used to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This form provides a comprehensive outline of the investigational drug, including information about the sponsor and the study protocol. It is essential in the drug approval process, playing a vital role in ensuring that all necessary information is presented for regulatory review.
The responsibilities of the sponsor are clearly defined within the form, which includes duties such as initiating and conducting the investigation. Understanding the nuances of Form FDA 1571 helps ensure compliance with FDA regulations and facilitates smooth communication between the sponsor and the regulatory agency.

Purpose and Benefits of the Form FDA 1571

The purpose of Form FDA 1571 extends beyond mere submission; it is cornerstone for the drug development process. By accurately filling out the FDA clinical trial form, sponsors benefit from clear guidelines and structured communication with the FDA. This form also helps to ensure patient safety by addressing critical aspects of the clinical investigation.
Through the submission of the IND application, sponsors can actively participate in regulatory oversight, which in turn supports compliance with safety and efficacy standards. The drug clinical investigation form serves as a vital tool for maintaining transparency throughout the development process.

Who Needs to Complete Form FDA 1571?

The primary users of Form FDA 1571 are sponsors involved in drug development. A sponsor is defined as any individual or entity that takes responsibility for the initiation and management of a clinical investigation. In some cases, additional parties may need to countersign the form to validate its contents.
Completion of the form is required in various scenarios, including new clinical trials and investigations involving new drug entities. Understanding who is obligated to fill out the FDA IND form is essential to meeting regulatory requirements and ensuring timely submission.

When and How to Submit the Form FDA 1571

Determining the correct timing for submitting Form FDA 1571 is fundamental to the success of the investigational study. The submission methods vary; sponsors can file online or by traditional mail. Each method has specific guidelines that must be followed to ensure compliance.
Consequences for late filings or non-compliance can be significant, potentially delaying the investigation or resulting in regulatory action. Therefore, being aware of submission timelines and procedures is crucial for all parties involved.

How to Fill Out the Form FDA 1571 - Step-by-Step Instructions

Filling out Form FDA 1571 correctly requires attention to detail and a thorough understanding of its sections. Key sections include details about the sponsor, the investigational drug, and the proposed study design. Gathering accurate and complete information is vital to avoid common errors that may delay processing.
  • Review each section of the form and understand the required information.
  • Ensure that the sponsor’s information is accurate and complete.
  • Check for consistency with other submitted documents.
  • Avoid common mistakes such as incorrect signatures or missing data.

Review, Validation, and Signature Requirements for Form FDA 1571

Review and validation of Form FDA 1571 are crucial steps before submission. Proper validation helps identify any discrepancies or incomplete information that could hinder the approval process. There is a clear distinction between digital signatures and wet signatures, each of which has specific requirements for authenticity.
Required signatories typically include the sponsor and may also require an attorney or agent to countersign. Understanding these signature requirements is essential to ensuring the form is considered valid by the FDA.

Security and Compliance When Handling Form FDA 1571

When dealing with Form FDA 1571, security and compliance are paramount. pdfFiller employs robust security measures to protect sensitive documents during the filling process. Compliance with HIPAA and GDPR regulations ensures that personal information is handled with care and integrity.
Protecting both patient and sponsor information is not just best practice; it is a regulatory requirement that must be adhered to throughout the form-filling process.

Post-Submission Process for Form FDA 1571

Once Form FDA 1571 is submitted, sponsors should expect to receive confirmation of their submission. Tracking options are available to monitor the status of the application. It is also important to be prepared for potential follow-up requests from the FDA for additional information or clarification.
If any corrections or amendments are necessary, guidance is available to assist sponsors in addressing these requests promptly and effectively.

Utilizing pdfFiller for Form FDA 1571 Completion

To streamline the completion process of Form FDA 1571, sponsors can utilize pdfFiller’s comprehensive tools. Features such as editing, signing, and secure document management simplify the filling experience significantly. Many users have shared success stories highlighting how pdfFiller has enhanced their ability to manage FDA forms efficiently.
Leveraging the advantages of pdfFiller not only improves the accuracy and security of submissions but also helps maintain compliance with regulatory standards.
Last updated on Mar 5, 2015

How to fill out the FDA 1571 IND

  1. 1.
    Begin by accessing pdfFiller and searching for 'Form FDA 1571'. Open the document among the results to access the fillable fields.
  2. 2.
    Familiarize yourself with the pdfFiller interface; you will see fillable fields, checkboxes, and options to add comments.
  3. 3.
    Before filling out the form, gather necessary information such as the sponsor’s details, drug information, and the clinical investigation phases.
  4. 4.
    Proceed to fill out each field carefully, ensuring that all information provided is accurate and complete. Use the interface tools to enter text and check applicable boxes.
  5. 5.
    Once you’ve completed all sections of the form, use pdfFiller’s built-in review tools to double-check your entries for any potential errors.
  6. 6.
    Finalize the form by ensuring that all required fields are filled and any necessary signatures are added. You may digitally sign using pdfFiller’s electronic signature feature if applicable.
  7. 7.
    Once satisfied with your completion, save the document using pdfFiller’s save options, which allows you to keep a copy for your records.
  8. 8.
    For submission, download the completed form in your desired format or use pdfFiller to submit it directly to the FDA if this option is available.
Regular content decoration

FAQs

If you can't find what you're looking for, please contact us anytime!
Only authorized representatives of study sponsors or individuals responsible for the clinical investigation can submit Form FDA 1571. Ensure that you match the eligibility criteria before initiating the submission process.
You need detailed information about the sponsor, drug being investigated, phases of the clinical investigation, and relevant details surrounding the study. Ensure you have all required data ready to fill in the form.
Form FDA 1571 can be submitted physically to the FDA or electronically if allowed. Use your completed form to follow the submission guidelines provided by the FDA once it is finalized.
Common mistakes include incomplete fields, missing signatures, and inaccuracies in drug or sponsor information. Carefully review all entries before submission to minimize errors.
While specific deadlines can vary based on project timelines, it’s crucial to submit Form FDA 1571 as early as possible in the planning stages of your clinical trial to facilitate timely review and approval.
Generally, there are no direct fees for submitting Form FDA 1571. However, various associated costs may occur throughout the drug approval process, which can vary depending on the trial's scope.
Processing times can vary based on the submission volume and specifics of each application. Plan for a waiting period for the FDA to review and respond to your application after submission.
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.